79,495 Shares in Revvity Inc. $RVTY Purchased by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. bought a new position in Revvity Inc. (NYSE:RVTYFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 79,495 shares of the company’s stock, valued at approximately $7,691,000.

A number of other hedge funds also recently made changes to their positions in RVTY. AQR Capital Management LLC lifted its position in shares of Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after buying an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after buying an additional 744 shares in the last quarter. Millennium Management LLC lifted its position in shares of Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after buying an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after purchasing an additional 189,871 shares during the period. Finally, Focus Partners Wealth raised its position in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after purchasing an additional 811 shares during the period. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. The Goldman Sachs Group decreased their price objective on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Weiss Ratings downgraded Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. Barclays upped their price objective on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Evercore upped their price objective on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research report on Tuesday, February 3rd. Finally, Wells Fargo & Company upped their price objective on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Four investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Revvity has an average rating of “Hold” and an average price target of $107.73.

Get Our Latest Stock Analysis on RVTY

Revvity Trading Up 0.3%

RVTY opened at $104.88 on Monday. The stock has a market cap of $11.70 billion, a price-to-earnings ratio of 50.18, a P/E/G ratio of 2.25 and a beta of 1.11. The stock’s 50 day moving average price is $92.03 and its 200-day moving average price is $97.27. Revvity Inc. has a one year low of $81.22 and a one year high of $118.30. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72.

Revvity (NYSE:RVTYGet Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The firm had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, equities analysts forecast that Revvity Inc. will post 5.32 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is currently 13.40%.

About Revvity

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Recommended Stories

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTYFree Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.